Indications | Strategy | Development Stage | ||||||
---|---|---|---|---|---|---|---|---|
Hit | Lead | Candidate | Pre-Clinical | Phase Ⅰ | Phase Ⅱ | Phasell Ⅲ | ||
Breast cancer | Hybrid small molecule | |||||||
Leukemia | PROTACs | |||||||
Alzheimer’s disease | PROTACs | |||||||
Small molecule | ||||||||
Acute coronary syndrome | Hybrid small molecule | |||||||
SARS-COV2 | Peptidomimetic | |||||||
Retinal diseases (Dry AMD) | Small molecule | |||||||
TB and non-infectious disease | Hybrid small molecule | |||||||
Retinal diseases | Repurposing | |||||||
Parkinson’s disease | HPAPI | |||||||
Gastric cancer | Small molecule | |||||||
Hair loss | Natural Product | |||||||
Rheumatoid arthritis | Natural Product | |||||||
Prostatits | Natural Product |